Background-Regional cardiac sympathetic hyperactivity predisposes to malignant arrhythmias in nondiabetic cardiac disease. Conversely, however, cardiac sympathetic denervation predicts increased morbidity and mortality in severe diabetic autonomic neuropathy (DAN). To unite these divergent observations, we propose that in diabetes regional cardiac denervation may elsewhere induce regional sympathetic hyperactivity, which may in turn act as a focus for chemical and electrical instability. Therefore, the aim of this study was to explore regional changes in sympathetic neuronal density and tone in diabetic patients with and without DAN. Methods and Results-PET using the sympathetic neurotransmitter analogue 11 C-labeled hydroxyephedrine ([ 11 C]-HED) was used to characterize left ventricular sympathetic innervation in diabetic patients by assessing regional disturbances in myocardial tracer retention and washout. The subject groups comprised 10 diabetic subjects without DAN, 10 diabetic subjects with mild DAN, 9 diabetic subjects with severe DAN, and 10 healthy subjects. Abnormalities of cardiac [
D
iabetic autonomic neuropathy (DAN) is a common complication of diabetes, present in up to 40% of insulin-dependent diabetic patients at diagnosis. 1 It has been invoked as a cause of sudden cardiac death in diabetic subjects both with and without myocardial ischemia. [2] [3] [4] [5] [6] [7] Absent heart rate variability secondary to DAN is predictive of both left ventricular failure and increased mortality. 6 Left ventricular function has been reported to be depressed in 59% of diabetic subjects with DAN compared with only 8% of those without DAN. 7 Longitudinal studies of DAN subjects have typically shown 5-year mortality rates ranging between Ϸ16% and 53%, [2] [3] [4] with the highest mortality rates corresponding to advanced cardiovascular sympathetic denervation. 4 In contrast, regional cardiac sympathetic hyperactivity is associated with the development of malignant ventricular arrhythmias and cardiac death in nondiabetic humans and animals, particularly when accompanied by reduced protective parasympathetic tone and myocardial ischemia. 8 -10 The association of increased cardiovascular mortality with decreased cardiac sympathetic innervation in severe DAN appears somewhat paradoxical, as does the enhanced protective effects of ␤-adrenergic receptor blockade in these subjects. [11] [12] [13] [14] Radiolabeled analogues of norepinephrine are actively taken up by the sympathetic nerve terminals of the heart and thereby permit direct regional assessment of cardiac sympa-thetic integrity. Cardiac scanning with 123 I-labeled metaiodobenzylguanidine ([ 123 I]-MIBG) has identified sympathetic denervation in most diabetic subjects with normal cardiovascular reflex testing, [15] [16] [17] with abnormalities of MIBG retention correlating with left ventricular dysfunction. 16 The radiotracer 11 C-labeled hydroxyephedrine ([ 11 C]-HED) has recently been developed as a norepinephrine analogue for PET. 18 -20 This has been shown to undergo highly specific uptake and retention in the sympathetic nerve terminals, 18 -20 which thus facilitate the quantitative regional characterization of sympathetic neuronal dysfunction and loss. 19 Studies using [ 11 C]-HED have shown that its retention is preferentially reduced in the distal left ventricular myocardium by diabetes. 19 We speculated that this distal denervation in DAN may elsewhere induce regional sympathetic hyperactivity, which could potentially become a focus of electrical and chemical instability.
In this article, we report the results of a study in which PET using [ 11 C]-HED was used to characterize sympathetic neuronal density and function in the proximal myocardial segments of diabetic subjects with and without DAN.
Methods

Subjects
The diabetic subjects were recruited from consecutive presentations to the Michigan Diabetes Research and Training Center Clinical Core. All the diabetic subjects included in this study had undergone assessment of myocardial perfusion with PET and [
13 N]NH 3 at rest and during maximal adenosine stimulation (140
21-23 within a 6-month period preceding this study to confirm the absence of coronary artery disease (CAD). The inclusion criteria for all diabetic subjects included a diagnosis of type 1 diabetes, age between 20 and 65 years, the absence or presence of DAN (as defined below), and the absence of any risk factors for other causes for neuropathy (determined by a medical history, family history, history of medications, occupational history, history of exposure to toxins, physical and neurological examinations, and laboratory studies). Exclusion criteria included preexisting cardiovascular disease, including CAD, congestive heart failure, known arrhythmias, documented ventricular structural abnormalities and valvular disease, peripheral vascular disease, and uncontrolled hypertension; a history of primary dyslipidemia requiring therapy; a creatinine clearance Ͻ70 mL/min; or a history of previous kidney, pancreas, or cardiac transplantation.
Diabetic subjects were categorized by cardiovascular reflex testing into diabetic subjects without DAN (DAN free), diabetic subjects with mild DAN, and subjects with severe DAN. These diabetic subjects were compared with healthy age-matched nondiabetic subjects (3 men, 7 women). Clinical details are given in Table 1 . DAN-free diabetic subjects (6 men, 4 women) were selected on the basis of having Յ1 abnormality on standardized testing and no symptoms of DAN. Mild DAN subjects (5 men, 5 women) had 2 to 3 abnormal cardiac autonomic function tests (4 had symptoms from delayed gastric emptying), and severe DAN subjects (4 men, 5 women) had Ն4 abnormal cardiac autonomic function tests and symptoms attributable to autonomic neuropathy. All severe DAN subjects reported early satiety, nausea, periodic vomiting, persistent constipation with periodic episodes of diarrhea, and dizziness on standing. Four suffered from periodic episodes of urinary retention requiring catheterization. Written informed consent was obtained from all patients, and the study protocol was approved by the institutional review board of the University of Michigan.
Autonomic Function Testing
Cardiovascular autonomic neuropathy was assessed by use of a battery of autonomic function tests to evaluate heart rate variability. All subjects were fasted and had abstained from both prescription and nonprescription medications on the day of assessment. Subjects were instructed to delay their morning insulin injection until after testing and were excluded if they had experienced a hypoglycemic episode within 8 hours of testing. Blood glucose values were within the range of 8 to 14 mmol/L during the assessment period.
Heart rate variability was measured for 6 minutes with patients in the supine position breathing at a fixed rate of 5 breaths per minute by standardized protocol. 24 First, the E/I ratio 25 (R-R max /R-R min ) over 25 breaths was determined. Spectral analysis was then used to quantify defects in sympathetic and vagal innervation of the heart. 26 The power spectrum of heart rate variability was determined in low (0.01 to 0.05 Hz), middle (0.05 to 0.15 Hz), and high (0.15 to 0.5 Hz) frequency ranges. Abnormality was defined as results that were below the 2.3 percentile for age. 27 A 5-minute postural study was also performed in which the change in the blood pressure on standing was assessed after 20 minutes of the patient lying supine. The lowest standing systolic pressure was used to calculate postural change in blood pressure. The Valsalva maneuver 24 was then performed twice, and the mean Valsalva ratio was calculated.
PET Studies and Image Construction
Patients taking medications or substances (including caffeine) known to interfere with neuronal uptake of norepinephrine analogues abstained from such substances for Ն2 weeks before study. Cardiac PET imaging was performed in a whole-body PET scanner (model CTI 931 and Siemens/ECAT 931) with 20 mCi of [ 11 C]-HED and 20 mCi of [ 13 N]NH 3 . 19 This scanner has 8 circular detector rings that allow the simultaneous acquisition of 15 contiguous transaxial images (oriented perpendicular to the sagittal and coronal planes of the body) with a slice thickness of 6.75 mm. After introduction of a 22-gauge intravenous cannula into the antecubital vein and placement of the tomograph with the aid of a scout image, a 15-minute transmission study with a retractable germanium-68 ring source was performed to correct emission data for tissue attenuation. Dynamic scan acquisition was initiated simultaneously with the injection of [ 11 C]-HED. The image acquisition protocol comprised 15 images with varying frame duration (6ϫ30, 2ϫ60, 2ϫ150, 2ϫ300, 2ϫ600, and 1ϫ1200 seconds). The emission data were corrected for attenuation and reconstructed by filtered backprojection with a Hanning filter with a cutoff frequency of 1.12 cycles per 1 cm to produce images with a resolution of 9 to 10 mm at full width at halfmaximum in-plane. A Sun workstation (Sun Microsystems) was used to realign the images perpendicular to the long axis of the left ventricle, yielding 8 short-axis views (slice thickness, 0.8 cm) of myocardial tracer distribution extending from the apex to the base of the left ventricle. After waiting 1 hour for the [ 11 C] to decay after the end of data acquisition, we evaluated resting myocardial perfusion using [ 13 N]NH 3 . 11 C]-HED images. The left ventricular myocardium was depicted on the map with the apex at the center. The mean relative tracer activity value was determined 19 within each left ventricular region (divided into apical, anterior, septal, inferior, and lateral myocardial segments). Apical values were obtained by averaging together all sectors in the 2 most apical short-axis slices. Distal values for the other segments were obtained by averaging together the appropriate sectors in the 3 planes adjacent to the 2 apical planes. Similarly, the corresponding proximal values were obtained by use of the final 3 short-axis slices toward the base of the heart. Reference values were obtained from a separate group of normal subjects. They were processed and averaged together to determine the homogeneity of retention in the healthy left ventricle. No regional differences in relative [
11 C]-HED retention were found in the normal subjects, which was in agreement with previous reports 19 and confirms homogeneous uptake of ]-HED retention in the reference subjects by Ͼ2.5 SD) was defined as abnormal. Thus, the calculated z scores represent a validated 19 measure of the individual subject's myocardial tracer retention heterogeneity, with an increase in heterogeneity being consistent with distal left ventricular denervation. 19 The "extent" of the heterogeneity was expressed as the percentage of sectors in the polar map that were abnormal, ie, z i Ͼ2.5.
Retention Index Calculation
To quantify changes in regional myocardial uptake of [ 11 C]-HED, absolute [ 11 C]-HED retention in the proximal and distal left myocardium was measured with a "retention index" approach as previously reported 19 that corrects [ 11 C]-HED retention for myocardial tracer delivery. Absolute tissue retention of [ 11 C]-HED between 40 and 60 minutes after injection was measured for distal and proximal anterior, septal, inferior, and lateral myocardial segments by averaging the appropriate sectors from the last 2 frames of the dynamic data set. Mean tracer counts per pixel within the myocardial regions were determined. To correct this measurement for the amount of tracer delivered to the myocardium, retention was divided by the total counts in the blood over the time period from injection to 60 minutes later. Total blood counts were determined from the area under the time-activity curve for a small region of interest (5ϫ5 pixels) placed at the center of the left ventricular blood pool on a basal plane. This yielded a [
11 C]-HED retention index as follows: retention index (mL blood ⅐ min Ϫ1 ⅐ mL tissue Ϫ1 ) equals tissue counts between 40 and 60 minutes divided by blood counts from time 0 to 60 minutes.
For plots of time-activity data, the measured PET counts were converted to units of megabecquerel per milliliter by multiplying by the PET scanner calibration factor, which has units of megabecquerel per milliliter per PET count. This calibration factor is determined weekly by imaging a 20-cm cylindrical flood phantom filled with an aqueous solution of [ 18 F] at a known concentration.
Quantitative Evaluation of Regional Myocardial Perfusion
PET using [ 13 N]NH 3 allows accurate quantification of regional myocardial blood flow, 21, 22 with the flow values agreeing closely with those obtained by invasive techniques. 23 The time course of tracer distribution in myocardium and blood was defined by dynamic image acquisition using a previously described method. 21, 23 After the transmission scan, 20 mCi of [
13 N]NH 3 was administered into the antecubital vein over 30 seconds. Dynamic scan acquisition for this study was initiated with varying frame duration (12ϫ10 seconds/ 6ϫ30 seconds/2ϫ300 seconds). Twelve myocardial regions per plane were defined in the 8 planes in the last time frame of the dynamic study sequence. After correction for subject motion, the dynamic image set was sampled, and 96 (8 planesϫ12 regions) time-activity curves were stored for further analysis. Arterial input function was determined from circular regions at the 2 most basal planes corresponding to the large blood pool at the center of the largest left ventricle diameter of the resliced images. A previously validated tracer kinetic model 23 
Statistical Analysis
Statistical analysis was performed by use of Super ANOVA (Abacus Concepts Inc). Differences among experimental groups were detected by ANOVA, and the significance of differences between these groups was assessed by the Student-Newman-Keuls multiple range test. If the variances for the variables were found to differ significantly, a logarithmic transformation was performed that corrected the unequal variances. All analyses were then performed on the transformed data. Data in the text are given as meanϮSD. Significance was defined at Pϭ0.05.
Results
Regional Myocardial Perfusion
The presence of regional discrete perfusion defects consistent with occult CAD were evaluated by visual and quantitative analyses of myocardial blood flow at rest. All subjects had homogeneous [
13 N]NH 3 retention on visual inspection of standardized color-coded blood flow images taken from the vertical and horizontal long axes and the distal and proximal short axes of the left ventricle. Resting regional myocardial blood flow was similar in nondiabetic and DAN-free diabetic subjects but was increased by 26% to 46% in the subjects with mild and severe DAN, respectively (Table 2) . Resting global flow was higher in all myocardial segments in the DAN subjects compared with the other subject groups, with no regional differences in flow emerging.
Regional Ventricular [ 11 C]-HED Retention
Abnormalities of regional [ 11 C]-HED retention in the 3 groups of diabetic subjects are shown in Figure 1 . Of the 10 DAN-free subjects, 4 were found to have regional abnormalities in [
11 C]-HED retention, affecting from 4% to 
8% of the left ventricular map (5Ϯ2%).
Of the 10 mild DAN subjects, 9 were also found to have similar tracer defects affecting from 3% to 17% of the left ventricular map (6Ϯ5%, PϭNS versus DAN-free subjects). All severe DAN subjects were found to have extensive [ 11 C]-HED retention defects, ranging from 21% to 79% of the left ventricular area (48Ϯ19%, PϽ0.01 versus mild DAN and DAN-free diabetic subjects). In the mild DAN subjects, defects were observed only in the distal inferior wall of the left ventricle, whereas in the severe DAN subjects, defects extended to involve the distal and proximal anterolateral and inferior walls. The ability of the currently available reflex tests of autonomic function to correctly classify subjects free of DAN (specificity) was 0.86, and their ability to correctly classify those with DAN (sensitivity) was 0.67.
Measurements of the absolute tissue retention index for [
11 C]-HED in the proximal and distal myocardial segments in the DAN-free diabetic subjects were not significantly different from those of the healthy nondiabetic subjects, consistent with previous reports. 19, 28 Absolute [ 11 C]-HED retention was found to be increased by 33% (PϽ0.01) in the proximal segments of the severe DAN subjects compared with the same regions in the DAN-free subjects (30%; PϽ0.01 greater than the proximal segments of the mild DAN subjects) (Figure 2 ). The increase in [
11 C]-HED retention in the proximal segments of the severe DAN subjects appeared not to reflect increased tracer delivery because myocardial blood flow was not significantly different in these segments compared with the mild DAN subjects (Table 2 ). Distally, [
11 C]-HED retention was decreased in severe DAN by 33% compared with the DAN-free diabetic subjects (PϽ0.01) (and 21% [PϽ0.05] compared with mild DAN subjects) ( Figure  2 ). The 14% reduction in absolute [ 11 C]-HED retention in the distal myocardial segments of the mild DAN subjects was not statistically different from the DAN-free diabetic subjects (Pϭ0.1). Figure 3A demonstrates the PET images taken from a 35-year-old female subject with severe DAN who, after 33 years of diabetes, had both symptoms of DAN (gastroparesis, bladder dysfunction, and postural hypotension) and abnormalities in all her autonomic function tests. Blood flow images appear normal. [ 11 C]-HED retention, however, was markedly heterogeneous, with only the proximal anterior cardiac segments demonstrating visible [ 11 C]-HED retention. The tracer retention index was abnormally elevated in the proximal segments (0.219Ϯ0.02 min
Ϫ1
) and decreased distally (0.050Ϯ0.002 min Ϫ1 ) ( Figure 3B ). To explore neuronal synaptic vesicular integrity in the proximal and distal myocardial segments, comparative regional time-activity curves were generated in a severe DAN (Figure 4 ). Unlike HED, epinephrine is a substrate for monoamine oxidase, 28 so its neuronal retention is largely dependent on highly efficient vesicular storage. 28 Regional time-activity curves for [
11 C]-labeled epinephrine paralleled those generated with [
11 C]-HED, suggesting that vesicular storage mechanisms are intact in the proximal myocardial segments but defective distally. Sympathetic hyperactivity and increased regional norepinephrine levels competitively decrease the retention of sympathetic neurotransmitter analogues, including HED, by accelerating their washout. 18 However, under resting conditions, no significant washout of [ 11 C]-HED is normally observed in healthy nondiabetic myocardium. 28 Regional [ 11 C]-HED timeactivity washout curves were therefore used to explore whether sympathetic tone was elevated (and hence washout was increased) in the proximal myocardial segments of the severe DAN subjects. In these subjects, no washout of [ 11 C]-HED was observed in the proximal segments, because tissue [ 11 C]-HED activity was constant between 6.25 and 50 minutes ( Figure 5 ). In contrast, in the distal myocardial segments of the severe DAN subjects, rapid [ 11 C]-HED retention washout was observed over this time period. We have previously reported that administration of desipramine to healthy subjects decreases [ 11 C]-HED retention throughout the left ventricle by 50 minutes after injection to 34% of control values. 28 Therefore, the lack of washout of [ 11 C]-HED in the proximal myocardial segments of severe DAN patients paralleled that observed in healthy myocardium, but its accelerated washout in the distal myocardium is observed in healthy subjects only after the administration of desipramine.
Discussion
We have used PET and [
11 C]-HED to directly explore regional changes in sympathetic neuronal density and tone in diabetic subjects with differing severity of DAN. Abnormalities of cardiac sympathetic innervation were detected in 40% of DAN-free diabetic subjects, with deficits beginning distally but sparing the proximal myocardial segments even in severe DAN subjects. In severe DAN, absolute [ 11 C]-HED retention was found to be paradoxically increased in the proximal myocardial segments, while distally [
11 C]-HED retention was decreased. No appreciable washout of the tracer was observed in the proximal segments, consistent with increased sympathetic innervation but normal regional tone. In the distal myocardium, increased [ 11 C]-HED washout in severe DAN reproduced that observed in the myocardium of desipramine-treated healthy subjects, 28 suggesting distal neuronal uptake-1 dysfunction or neuronal loss. These data suggest that diabetes may result in left ventricular sympathetic dysinnervation with proximal hyperinnervation accompanying distal denervation, which in combination could result in potentially life-threatening myocardial electrical instability.
The marked heterogeneity of regional Resting myocardial blood flow was higher in DAN subjects than in nondiabetic and DAN-free diabetic subjects, which may reflect the resting tachycardia that accompanies DAN. 4, 5 However, comparison of blood flow in the proximal myocardium of mild and severe DAN subjects did not reveal a difference, suggesting that differences in tracer delivery could not explain the increase in tracer retention in these segments in the severe DAN subjects. The integrity of neuronal vesicular storage in the proximal myocardial segments of severe DAN subjects was confirmed by the demonstration that washout of [
11 C]-labeled epinephrine paralleled [ 11 C]-HED, because nonvesicular epinephrine would be rapidly metabolized. 29 In contrast, enhanced washout of [ 11 C]-HED in the distal myocardial segments of the severe DAN subjects parallels that observed in the myocardium of desipraminepretreated normal subjects 28 (albeit of greater magnitude in DAN, potentially reflecting incomplete pharmacological block of neuronal uptake-1) and suggests that failure of distal [
11 C]-HED retention in DAN specifically reflects impaired neuronal tracer uptake resulting from uptake-1 dysfunction or neuronal loss. Proximal myocardial hyperinnervation could result from a persistent increase in axonal sprouting and regeneration that normally precede organ reinnervation. 30, 31 Dense innervation of the proximal versus distal myocardium may contribute to its resistance to denervation and serve as a foundation for ventricular reinnervation, which normally proceeds from the base of the heart to the apex. 32 In nondiabetic animals, organ reinnervation after partial denervation requires axonal sprouting and hyperinnervation initially within the islands of remaining innervation, 30, 31 which then becomes downregulated as distal reinnervation is completed. In severe DAN, failure of successful distal reinnervation may lead to a sustained increase in proximal neuronal density. Increased proximal myocardial [ 11 C]-HED retention was not observed in the mild DAN subjects in whom the extent of the distal [
11 C]-HED retention defect averaged only 13% of that observed in the severe DAN subjects. It is thus tempting to speculate that there may exist a threshold for distal left ventricular denervation to initiate unsuccessful proximal regeneration and repair. We proposed that sympathetic hyperactivity may be present in the proximal myocardium of the severe DAN subjects. In experimental diabetes, increased sympathetic tone has been etiologically invoked in nerve conduction slowing, 33 and increased sympathetic activity in the rat diabetic myocardium is reported to precede chronic sympathetic denervation. 34, 35 Increased regional norepinephrine levels resulting from increased sympathetic tone would be expected to decrease [ 11 C]-HED retention and accelerate washout. 18 However, the findings that [ 11 C]-HED retention was increased and washout was unchanged in the proximal myocardial segments in severe DAN suggest that sympathetic tone was not abnormally elevated in these regions. In DAN, cardiac sympathetic dysinnervation in conjunction with parasympathetic denervation 4,5 may contribute to the excess of cardiac deaths in diabetic patients. [2] [3] [4] [5] [6] [11] [12] [13] [14] In nondiabetic subjects, decreased protective parasympathetic tone and heterogeneous sympathetic cardiac innervation are thought to contribute to sudden death. 36 -39 Increased regional sympathetic innervation may predispose to ventricular fibrillation by decreasing the arrhythmogenic threshold. 39 Regional cardiac sympathetic hyperactivity increases the risk of cardiac arrhythmias during myocardial ischemia, 10, 37 and selective cardiac sympathetic denervation or ␤-blockers [11] [12] [13] [14] 37 reduce the risk of both cardiac arrhythmias and sudden death in these patients, implicating regional sympathetic imbalance as a factor promoting arrhythmogenesis. Diabetic patients have increased mortality after myocardial infarction, 11-14,40 -42 which may reflect the extent of CAD or increased susceptibility to other triggering factors, 40 -42 including autonomic imbalance. [2] [3] [4] [5] [6] [7] The decrease in heart rate variability observed in the DAN subjects in this study, despite preservation of proximal myocardial sympathetic innervation, is consistent with regional or global myocardial parasympathetic denervation, 4, 5 which may contribute to electrical imbalance. In diabetes, DAN has been directly implicated in depressed diastolic filling and decreased resting left ventricular ejection fraction. 16, 43 In diabetic subjects complicated by myocardial infarction, DAN is predictive of both increased mortality and left ventricular failure. 44 Compared with nondiabetic subjects, diabetic patients experience greater cardioprotection with ␤-blockade 11-14 with highly significant reductions in postinfarct mortality 13 despite poorer risk factor profiles, implicating a role for cardiac adrenergic hyperactivity. In DAN patients, ␤-blockade with atenolol typically slows the elevated resting heart rate, 45 an effect that requires residual sympathetic tone and is thus consistent with our demonstration of persistent sympathetic innervation even in advanced DAN. Potentially, proximal myocardial sympathetic hyperinnervation could promote regional myocardial perfusion imbalances by decreasing myocardial vascularity, 46 by stimulating vascular hyperreactivity, 47 and by contributing to paradoxical coronary vasoconstriction, 48 thereby increasing cardiac mortality. In addition, increased norepinephrine levels in these proximal segments may contribute to malignant arrhythmogenesis by precipitating myocardial necrosis 49 secondary to increased intracellular calcium and free radical injury. 50 Therefore, these islands of hyperinnervation may be the focus of electrical, chemical, and vascular instability, particularly if denervation hypersensitivity is also present.
In summary, our studies have demonstrated that diabetes may result in left ventricular sympathetic dysinnervation with proximal hyperinnervation complicating distal denervation. This exaggerated sympathetic imbalance may contribute to the accelerated rate of cardiac death in diabetes. Therefore, instead of avoiding the use of ␤-blocking drugs in DAN, we may need to reconsider their potential benefits in this group of high-risk patients.
